ClinicalTrials.gg
CompletedNCT06009575Updated Aug 24, 2023

Local Culture-Based Nutrition Education Intervention on Iron Supplement Tablets (IST) Consumption Compliance in Female Adolescents at Ogan Komering Ilir Regency: A Quasi-Experimental Protocol Study

A Phase 3 interventional study of Iron Supplement Tablets in Anemia and Iron Deficiency Anemia, sponsored by Universitas Sriwijaya. Completed at 1 site in Indonesia. Open to female participants aged 11 Years to 18 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-08-24.

Sponsored by Universitas Sriwijaya · Phase 3, Interventional, and Prevention

From the registry’s dates

  • Registered 2 years 1 month after the study started (first participant enrolled Jul 2021, registered Aug 2023).
Phase
Phase 3
Study type
Interventional
Enrollment
126
Allocation
Randomized
Ages
11 Years to 18 Years
Sex
Female
01

Study summary

The goal of this clinical trial is to test the impact of a local culture-based nutritional education intervention on IST consumption compliance among female adolescents in the Ogan Komering Ilir Regency. The main questions it aims to answer are:

a To identify information for the development of a local culture-based nutrition education model and to build a ready-to-implement local culture-based nutrition education model.

b. To evaluate the implementation of the Anemia Prevention and Control Program among female adolescents in Ogan Komering Ilir Regency.

c. To test the impact of the local culture-based nutrition education model on the improvement of knowledge, attitude, and IST consumption compliance among female adolescents.

Participants will received IST and local culture-based nutrition education. Researchers will compare control group received IST as the Ministry of Health's program for the prevention of anemia with a subsidy for providing IST

02

Conditions studied

  • Anemia
  • Iron Deficiency Anemia

Keywords

  • anemia
  • Iron Supplement Tablets
03

In context

Anemia

1,768 studies on the registry are indexed under Anemia; 244 are open to participants now.

This study's enrollment of 126 is above the median of 96 across 1,318 interventional studies indexed under Anemia.

Browse Anemia studies →

Lead sponsor

Universitas Sriwijaya is the lead sponsor of 19 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
11 Years to 18 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • public schools have received the IST program from the government, and the distance between schools is at least 10 kilometers
  • students enrolled in grade 11, age range 15-17 years, menstruating, owning a smartphone, having an Instagram account, and obtaining parental approval to participate in this study

Exclusion criteria

Exclusion Criteria:

  • schools that are currently the object of another study and are difficult to reach (remote areas)
  • students who have a BMI value≤ -3 SD and do not watch complete educational videos for the sample in the intervention group
05

Study design

Phase
Phase 3
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Investigator)
Enrollment
126 participants (actual)

Study arms

  • Experimental
    intervention group

    Dietary Supplement: Iron Supplement Tablets

  • Active comparator
    control group

    Dietary Supplement: Iron Supplement Tablets

Interventions

  • Dietary supplementIron Supplement Tablets

    The intervention group received IST and local culture-based nutrition education

06

What researchers measure

Primary outcomes

  1. Educational Intervention

    The local culture to be used was based on the results of a qualitative study conducted prior to the intervention, where Kelakar Betok is the local culture preferred by female adolescents, used as a means of nutrition education. Subsequently, the social media used in nutrition education publicity is Instagram. Nutrition education is provided in the form of educational videos based on local culture broadcasted through the Instagram account @remaja.bebasanemia.

    Time frame: 12 Weeks

  2. Iron Supplement Tablet (IST) Administration

    The IST used as an intervention consists of IST containing 60 mg FeSO4 and 400 mcg of folic acid, which is a government program. The program policy for administering IST to female adolescents is carried out once a week in the year, which was given in a blanket approach. This supplementation was carried out at educational institutions. The schools that receive iron tablets are Junior High Schools and Senior High Schools

    Time frame: 16 Weeks

07

Study locations

1 site
  • Anita Rahmiwati
    Palembang, South Sumatera 30139, Indonesia
08

References and documents

Individual participant data

Plan to share: Undecided — Study Protocol Statistical Analysis Plan (SAP)

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jul 2021 to primary completion in Jan 2022, 6 months.

Of 58 non-industry phase 3 interventional studies under Anemia, half reached primary completion within 32 months of starting (the median), counting those still running; a quarter within 20 and three quarters within 59. This study's 6 months is below that.

Counting every sponsor, half of 167 studies reached it within 24 months; a quarter within 15 and three quarters within 49.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 19, 2023
First posted
Aug 24, 2023
StartActual
Jul 1, 2021
Primary completionActual
Jan 31, 2022
CompletionActual
Jan 31, 2022
Last update
Aug 24, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 24, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06009575
Lead sponsor
Universitas Sriwijaya
Collaborators
Universitas Indonesia
Responsible party
Anita Rahmiwati (Dr, Universitas Sriwijaya) — Principal investigator
First posted
Aug 24, 2023
Start date
Jul 1, 2021
Primary completion
Jan 31, 2022
Completion
Jan 31, 2022
Last update
Aug 24, 2023

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Iron Supplement

Start the discussion